Immuvac: Clinical Trials

3 trials of Immuvac, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Immuvac: new trials by email Literature Review of Immuvac trials Research Report on Immuvac

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis
Prednisolone, Mycobacterium w immunotherapy - Tuberculous Pericarditis
Phase 3CompletedUniversity of Cape Town14002008-12-012014-09-03
Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
Intradermal injection of Mycobacterium w - Tuberculosis
Phase 3CompletedMinistry of Science and Technology, India3002007-03-012013-04-26
Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients
Intra-dermal administration of Mycobacterium w - Tuberculosis
Phase 3CompletedMinistry of Science and Technology, India10202005-03-012014-01-06

Conditions studied

Tuberculosis (2)  ·  Tuberculosis, Pulmonary (2)  ·  Pericarditis, Tuberculous (1)

Sponsors

Ministry of Science and Technology, India (2)  ·  University of Cape Town (1)

Countries

India (2)  ·  South Africa (1)

Top investigators

Bindu Dey, Ph.D. (2)  ·  Salim Yusuf, M.D. (1)  ·  Surendra K Sharma, M.D., Ph.D. (1)  ·  Surendra K Sharma, MD, Ph.D. (1)

Results publications

PMID 25178809